Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2026-02-20 @ 6:41 PM
Study NCT ID:
NCT00382395
Status:
SUSPENDED
Last Update Posted:
2015-09-18
First Post:
2006-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Sponsor:
SOLX, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
None
Primary Completion Date:
2017-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-07
Completion Date Type:
ESTIMATED
First Submit Date:
2006-09-27
First Submit QC Date:
None
Study First Post Date:
2006-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-17
Last Update Post Date:
2015-09-18
Last Update Post Date Type:
ESTIMATED